Black cohosh is a popular botanical extract often considered by women seeking support during midlife and menopause. As with any supplement, understanding its potential effects, particularly on vital organs like the liver, is a common and important concern.
This article aims to provide an evidence-based overview of black cohosh liver safety, addressing concerns and reviewing the available research to help you make informed choices.
Understanding Liver Concerns with Black Cohosh
Concerns regarding black cohosh and liver health have emerged over time, primarily from case reports suggesting a possible link between black cohosh consumption and liver issues. These reports have prompted closer examination of the botanical’s safety profile [1][2][3]. While such reports are valuable for identifying potential issues, establishing a direct cause-and-effect relationship can be complex.
A systematic review of black cohosh safety conducted in 2003 concluded that there was no clear evidence of an association between black cohosh and liver toxicity based on the data available at that time [4]. However, subsequent individual case reports continued to raise questions, including instances of abnormal liver function tests and more severe liver complications [3][1].
Challenges in Assessing Causality: The Role of Adulteration
One significant challenge in determining the true impact of black cohosh on the liver is the potential for product adulteration. Studies have highlighted that many commercial products marketed as black cohosh may contain other species of Actaea or even entirely different plant materials [5][6]. These other species may have different chemical compositions and potentially different effects on the body, including the liver.
For example, some Actaea species contain compounds like coclaurine, which can be metabolized into substances such as higenamine. Higenamine is a compound with stimulant properties and is considered a banned substance in sports, indicating its biological activity [7]. The presence of such unlisted compounds in a product labeled as black cohosh could lead to adverse effects mistakenly attributed to genuine black cohosh.
The complexity of assessing whether a reported liver issue is truly due to Cimicifuga racemosa (the botanical name for black cohosh) or an adulterant is a critical aspect of causality assessment [8].
Reviewing the Broader Evidence on Liver Effects
Despite the case reports, a comprehensive review of black cohosh-induced toxicity and adverse clinical effects published in 2025 provides a more current perspective. This review synthesizes a wide range of data, acknowledging the existence of reported liver issues but also considering the broader context of black cohosh use and research [9].
It’s important to distinguish between isolated case reports and findings from larger, controlled studies. While individual cases can signal potential concerns, they do not establish widespread risk or a direct cause for the general population. The overall body of evidence, especially when considering the widespread use of black cohosh, suggests that severe liver issues are relatively infrequent.
What to Consider for Liver Safety
Given the complexities, several factors are important when considering black cohosh and liver safety:
First, product quality and authenticity are paramount. Choosing reputable brands that engage in rigorous quality control and verify the identity of their botanical ingredients may help reduce the risk of consuming adulterated products [5]. Ensuring a product contains only Cimicifuga racemosa and not other Actaea species or unlisted compounds is crucial.
Second, individual susceptibility varies. Factors such as pre-existing liver conditions, concurrent medication use, and individual metabolic differences could influence how a person responds to any supplement, including black cohosh. Some reports have linked black cohosh use with conditions like autoimmune hepatitis, though the direct causal link remains debated [2].
Finally, monitoring for symptoms is always advisable. If you experience any symptoms that could indicate liver issues, such as unexplained fatigue, dark urine, yellowing of the skin or eyes (jaundice), abdominal pain, or nausea, it’s important to discontinue use and consult a healthcare professional immediately.
References
- Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006
- Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause (New York, N.Y.), 2004
- Black cohosh: a cause of abnormal postmenopausal liver function tests. Climacteric : the journal of the International Menopause Society, 2008
- A systematic review of the safety of black cohosh. Menopause (New York, N.Y.), 2003
- Phytochemical fingerprinting to thwart black cohosh adulteration: a 15 Actaea species analysis. Phytochemical analysis : PCA, 2011
- Metabolic profiling of Actaea species extracts using high performance liquid chromatography coupled with electrospray ionization time-of-flight mass spectrometry. Journal of chromatography. A, 2011
- Metabolism of coclaurine into the WADA-banned substance higenamine: a doping-relevant analytical evaluation of Kampo extracts. Journal of natural medicines, 2025
- Suspected black cohosh hepatotoxicity–challenges and pitfalls of causality assessment. Maturitas, 2009
- Review of black cohosh-induced toxicity and adverse clinical effects. Journal of environmental science and health. Part C, Toxicology and carcinogenesis, 2025
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
